Although Art Sherman was considering running California Chrome in the San Diego Handicap (gr. II) and Pacific Classic (gr. I) at Del Mar this summer without Lasix, the trainer said July 17 he'll likely use it as a precaution.
AAEP Racing Committee presented at the Welfare and Safety of the Racehorse Summit June 28 at Keeneland.
Though many local veterinarians voiced opposition once again, the California Horse Racing Board approved the third-party administration of race-day Lasix June 16 during a meeting at Santa Anita Park.
In a presentation at the RCI conference March 23 in New Orleans, Jockey Club executive director Matt Iuliano highlighted studies examining the efficacy of administering furosemide at least 24 hours before a race.
The AAEP has identified areas it believes are central to understanding exercise-induced pulmonary hemorrhage, and it hopes they determine future research into alternative methods of combating EIPH.
Perhaps research will end standoff
A study designed to determine the levels of exercise-industry pulmonary hemorrhage in 2-year-olds racing in South Florida is complete, but the data won't be released until a scientific paper is published after peer review.
Kentucky attorney general finds KHRC lacked authority to allow Lasix-free races, which could hinder Keeneland's plans to conduct such events in 2016.
The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
A Thoroughbred Owners and Breeders Association committee has renewed talks regarding a proposal to phase out use of race-day furosemide in graded stakes.
Churchill Downs announced Sept. 17 that it is working in partnership with other tracks, the Grayson-Jockey Club Research Foundation, and the AAEP to fund studies of the administration of furosemide.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16.
How would you handicap 'off-Lasix' horses?
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient."
The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding potential employment of third-party furosemide administration in the state.
Keen Ice rolls past American Pharoah in the Travers and more in the September 5, 2015 issue of Blood-Horse magazine.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
With an eye toward a possible proposal to change New York's rules on the race-day medication furosemide, the state's Gaming Commission met in Saratoga Springs Aug. 25 to solicit opinions about the medication.
At a forum designed to educate state regulators about furosemide, the very people the presentations were designed to enlighten may well have left with more questions than answers.
Two days after delaying steps to begin third-party administration of race-day furosemide, members of the California Horse Racing Board said they're still in support -- in concept -- of the proposal.
National Thoroughbred Racing Association officials reinforced the organization's impartial position on potential federal drug oversight in a legislative briefing with horsemen, owners, and horseplayers at Del Mar Aug. 21.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
A three-year effort to employ third-party administration of the race-day medication furosemide in California was delayed significantly at a California Horse Racing Board meeting Aug. 20 at Del Mar.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
At its Aug. 7 meeting, the Thoroughbred Racing Associations (TRA) board of directors reiterated its firm commitment to the implementation of uniform medication policies with a sense of urgency throughout the U.S.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.
The American Association of Equine Practitioners has released a "Prescription for Racing Reform" that includes "a commitment to identifying non-race day treatment alternatives for exercise-induced pulmonary hemorrhage."
Trainer Ralph Nicks dominated the two $65,000 Lasix-free races for 2-year-old fillies on Gulfstream Park's July 18 card.
A bipartisan bill introduced July 16 in the U.S. House of Representatives would see the U.S. Anti-Doping Agency create an independent organization for oversight of medication issues in horse racing.
A Salix-free race proved so popular at the entry box Wednesday that the over-subscribed field of 2-year-old fillies was split into two races for Saturday's program at Gulfstream Park.
Considering possible changes to the state's equine drug laws, New York regulators are calling together education, veterinary science, and industry experts to discuss the use of the anti-bleeding medicine furosemide.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
- By Tom LaMarra
United States Rep. Paul Tonko of New York said May 29 he will introduce federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication and drug testing.
Horses competing in the U.S. Triple Crown races fail to sweep the series because they are under too much pressure to perform in a short amount of time, Sheikh Hamdan told Reuters Africa in an interview published May 24.
On the 25th anniversary of their plucky colt’s Preakness Stakes (gr. I) win, Dogwood Stable’s Cot Campbell recalls the thrilling highs and gut-wrenching lows of campaigning a top 3-year-old along the 1990 Triple Crown trail.
A May 6 vote to change the recommended testing threshold for the anti-bleeding medication furosemide when it is administered 24 hours before a race triggered another debate and posed more questions.
Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
Prominent equine veterinarian Dr. Gary T. Priest has joined the Water Hay Oats Alliance, noting that he favors therapeutic medications for horses, but agrees they should be discontinued several days before a horse races.
Mubtaahij has never raced on the anti-bleeding medication Lasix, and he will run without it in the Kentucky Derby, becoming the first horse in 10 years to do so.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
New security measures will be employed for horses participating in the $1 million Toyota Blue Grass Stakes (gr. I), Keeneland announced March 25.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
A provision voiding the claim of a horse placed on the veterinarian's list for bleeding was approved for a 45-day public comment period by the California Horse Racing Board, though members expressed their concerns.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
Most Popular Stories
- Pletcher Breezes Four Kentucky Derby Hopefuls
- Classic Empire a Pro in Four-Furlong Move
- Espinoza Wins First Race After HOF Announcement
- Girvin Battling Quarter Crack, KY Derby Not Ruled Out
- Sano Star Gunnevera Goes Easy Five Furlongs
- Blinkers Likely for Practical Joke in Kentucky Derby
- O'Neill Confident After Irap's Mile Work
- BloodHorse.com Launches BackTrack Channel
- Vexatious Stands Out in Oaks Move
- Quiet Business Wins Bewitch on Keeneland's Closing Day